In summary, using electrospray liquid chromatography-tandem mass spectrometry for analyses of in vitro stimulated CD4+ T cells from MS patients and HCs, we were able to identify aberrant regulation of novel proteins, hitherto not identified through other approaches. Here, CD4 is linked to myeloid sarcoma.